|
1
|
Gros B and Kaplan GG: Ulcerative colitis
in adults: A review. JAMA. 330:951–965. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Segal JP, LeBlanc JF and Hart AL:
Ulcerative colitis: An update. Clin Med (Lond). 21:135–139. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Pabla BS and Schwartz DA: Assessing
severity of disease in patients with ulcerative colitis.
Gastroenterol Clin North Am. 49:671–688. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wangchuk P, Yeshi K and Loukas A:
Ulcerative colitis: Clinical biomarkers, therapeutic targets, and
emerging treatments. Trends Pharmacol Sci. 45:892–903. 2024.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lee SD: Health maintenance in ulcerative
colitis. Gastroenterol Clin North Am. 49:xv–xvi. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Cheng WW, Liu BH, Hou XT, Meng H, Wang D,
Zhang CH, Yuan S and Zhang QG: Natural products on inflammatory
bowel disease: Role of gut microbes. Am J Chin Med. 52:1275–1301.
2024. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zobeiri M, Momtaz S, Parvizi F, Tewari D,
Farzaei MH and Nabavi SM: Targeting mitogen-activated protein
kinases by natural products: A novel therapeutic approach for
inflammatory bowel diseases. Curr Pharm Biotechnol. 21:1342–1353.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Li YY, Wang XJ, Su YL, Wang Q, Huang SW,
Pan ZF, Chen YP, Liang JJ, Zhang ML, Xie XQ, et al: Baicalein
ameliorates ulcerative colitis by improving intestinal epithelial
barrier via AhR/IL-22 pathway in ILC3s. Acta Pharmacol Sin.
43:1495–1507. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wu X, Wei S, Chen M, Li J, Wei Y, Zhang J
and Dong W: P2RY13 exacerbates intestinal inflammation by damaging
the intestinal mucosal barrier via activating IL-6/STAT3 pathway.
Int J Biol Sci. 18:5056–5069. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wang X, Xie X, Li Y, Xie X, Huang S, Pan
S, Zou Y, Pan Z, Wang Q, Chen J, et al: Quercetin ameliorates
ulcerative colitis by activating aryl hydrocarbon receptor to
improve intestinal barrier integrity. Phytother Res. 38:253–264.
2024. View
Article : Google Scholar : PubMed/NCBI
|
|
11
|
Niu C, Hu XL, Yuan ZW, Xiao Y, Ji P, Wei
YM and Hua YL: Pulsatilla decoction improves DSS-induced colitis
via modulation of fecal-bacteria-related short-chain fatty acids
and intestinal barrier integrity. J Ethnopharmacol. 300:1157412023.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zong Y, Meng J, Mao T, Han Q, Zhang P and
Shi L: Repairing the intestinal mucosal barrier of traditional
Chinese medicine for ulcerative colitis: A review. Front Pharmacol.
14:12734072023. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Guo H, Guo H, Xie Y, Chen Y, Lu C, Yang Z,
Zhu Y, Ouyang Y, Zhang Y and Wang X: Mo3Se4
nanoparticle with ROS scavenging and multi-enzyme activity for the
treatment of DSS-induced colitis in mice. Redox Biol.
56:1024412022. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wang Y, Zhang J, Zhang B, Lu M, Ma J, Liu
Z, Huang J, Ma J, Yang X, Wang F and Tang X: Modified Gegen Qinlian
decoction ameliorated ulcerative colitis by attenuating
inflammation and oxidative stress and enhancing intestinal barrier
function in vivo and in vitro. J Ethnopharmacol. 313:1165382023.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhao Y, Luan H, Jiang H, Xu Y, Wu X, Zhang
Y and Li R: Gegen Qinlian decoction relieved DSS-induced ulcerative
colitis in mice by modulating Th17/Treg cell homeostasis via
suppressing IL-6/JAK2/STAT3 signaling. Phytomedicine.
84:1535192021. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wang Y, Lai W, Zheng X, Li K, Zhang Y,
Pang X, Gao J and Lou Z: Linderae Radix extract attenuates
ulcerative colitis by inhibiting the JAK/STAT signaling pathway.
Phytomedicine. 132:1558682024. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
He W, Liu M, Li Y, Yu H, Wang D, Chen Q,
Chen Y, Zhang Y and Wang T: Flavonoids from Citrus aurantium
ameliorate TNBS-induced ulcerative colitis through protecting
colonic mucus layer integrity. Eur J Pharmacol. 857:1724562019.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
He W, Li Y, Liu M, Yu H, Chen Q, Chen Y,
Ruan J, Ding Z, Zhang Y and Wang T: Citrus aurantium L. and
its flavonoids regulate TNBS-induced inflammatory bowel disease
through anti-inflammation and suppressing isolated jejunum
contraction. Int J Mol Sci. 19:30572018. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wu Q, Liu Y, Liang J, Dai A, Du B, Xi X,
Jin L and Guo Y: Baricitinib relieves DSS-induced ulcerative
colitis in mice by suppressing the NF-κB and JAK2/STAT3 signalling
pathways. Inflammopharmacology. 32:849–861. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Puppala ER, Aochenlar SL, Shantanu PA,
Ahmed S, Jannu AK, Jala A, Yalamarthi SS, Borkar RM, Tripathi DM
and Naidu VGM: Perillyl alcohol attenuates chronic restraint stress
aggravated dextran sulfate sodium-induced ulcerative colitis by
modulating TLR4/NF-κB and JAK2/STAT3 signaling pathways.
Phytomedicine. 106:1544152022. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yang NN, Yang JW, Ye Y, Huang J, Wang L,
Wang Y, Su XT, Lin Y, Yu FT, Ma SM, et al: Electroacupuncture
ameliorates intestinal inflammation by activating α7nAChR-mediated
JAK2/STAT3 signaling pathway in postoperative ileus. Theranostics.
11:4078–4089. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
He Z, Liu J and Liu Y: Daphnetin
attenuates intestinal inflammation, oxidative stress, and apoptosis
in ulcerative colitis via inhibiting REG3A-dependent JAK2/STAT3
signaling pathway. Environ Toxicol. 38:2132–2142. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wen J, Yang Y, Li L, Xie J, Yang J, Zhang
F, Duan L, Hao J, Tong Y and He Y: Magnoflorine alleviates dextran
sulfate sodium-induced ulcerative colitis via inhibiting JAK2/STAT3
signaling pathway. Phytother Res. 38:4592–4613. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Duan B, Hu Q, Ding F, Huang F, Wang W, Yin
N, Liu Z, Zhang S, He D and Lu Q: The effect and mechanism of
Huangqin-Baishao herb pair in the treatment of dextran sulfate
sodium-induced ulcerative colitis. Heliyon. 9:e230822023.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wang J, Zhang C, Guo C and Li X: Chitosan
ameliorates DSS-induced ulcerative colitis mice by enhancing
intestinal barrier function and improving microflora. Int J Mol
Sci. 20:57512019. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Bao X, Tang Y, Lv Y, Fu S, Yang L, Chen Y,
Zhou M, Zhu B, Ding Z and Zhou F: Tetrastigma hemsleyanum
polysaccharide ameliorated ulcerative colitis by remodeling
intestinal mucosal barrier function via regulating the
SOCS1/JAK2/STAT3 pathway. Int Immunopharmacol. 137:1124042024.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Deng B, Wang K, He H, Xu M, Li J, He P,
Liu Y, Ma J, Zhang J and Dong W: Biochanin A mitigates colitis by
inhibiting ferroptosis-mediated intestinal barrier dysfunction,
oxidative stress, and inflammation via the JAK2/STAT3 signaling
pathway. Phytomedicine. 141:1566992025. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ouyang F, Li B, Wang Y, Xu L, Li D, Li F
and Sun-Waterhouse D: Attenuation of palmitic acid-induced
intestinal epithelial barrier dysfunction by 6-shogaol in Caco-2
cells: The role of MiR-216a-5p/TLR4/NF-κB axis. Metabolites.
12:10282022. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Qu Y, Li X, Xu F, Zhao S, Wu X, Wang Y and
Xie J: Kaempferol alleviates murine experimental colitis by
restoring gut microbiota and inhibiting the LPS-TLR4-NF-κB axis.
Front Immunol. 12:6798972021. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wu XX, Huang XL, Chen RR, Li T, Ye HJ, Xie
W, Huang ZM and Cao GZ: Paeoniflorin prevents intestinal barrier
disruption and inhibits lipopolysaccharide (LPS)-induced
inflammation in Caco-2 cell monolayers. Inflammation. 42:2215–2225.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Spalinger MR, Sayoc-Becerra A, Santos AN,
Shawki A, Canale V, Krishnan M, Niechcial A, Obialo N, Scharl M, Li
J, et al: PTPN2 regulates interactions between macrophages and
intestinal epithelial cells to promote intestinal barrier function.
Gastroenterology. 159:1763–1777.e14. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Xiong T, Zheng X, Zhang K, Wu H, Dong Y,
Zhou F, Cheng B, Li L, Xu W, Su J, et al: Ganluyin ameliorates
DSS-induced ulcerative colitis by inhibiting the enteric-origin
LPS/TLR4/NF-κB pathway. J Ethnopharmacol. 289:1150012022.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Yuan SN, Wang MX, Han JL, Feng CY, Wang M,
Wang M, Sun JY, Li NY, Simal-Gandara J and Liu C: Improved colonic
inflammation by nervonic acid via inhibition of NF-κB signaling
pathway of DSS-induced colitis mice. Phytomedicine. 112:1547022023.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Wu Y, Jha R, Li A, Liu H, Zhang Z, Zhang
C, Zhai Q and Zhang J: Probiotics (Lactobacillus plantarum HNU082)
supplementation relieves ulcerative colitis by affecting intestinal
barrier functions, immunity-related gene expression, gut
microbiota, and metabolic pathways in mice. Microbiol Spectr.
10:e01651222022. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Jeong DY, Kim S, Son MJ, Son CY, Kim JY,
Kronbichler A, Lee KH and Shin JI: Induction and maintenance
treatment of inflammatory bowel disease: A comprehensive review.
Autoimmun Rev. 18:439–454. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Wang M, Fu R, Xu D, Chen Y, Yue S, Zhang S
and Tang Y: Traditional Chinese Medicine: A promising strategy to
regulate the imbalance of bacterial flora, impaired intestinal
barrier and immune function attributed to ulcerative colitis
through intestinal microecology. J Ethnopharmacol. 318:1168792024.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Alam F, Mohammadin K, Shafique Z, Amjad ST
and Asad MHHB: Citrus flavonoids as potential therapeutic agents: A
review. Phytother Res. 36:1417–1441. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Mirsepasi-Lauridsen HC: Therapy used to
promote disease remission targeting gut dysbiosis, in UC patients
with active disease. J Clin Med. 11:74722022. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Wu Y, Ran L, Yang Y, Gao X, Peng M, Liu S,
Sun L, Wan J, Wang Y, Yang K, et al: Deferasirox alleviates
DSS-induced ulcerative colitis in mice by inhibiting ferroptosis
and improving intestinal microbiota. Life Sci. 314:1213122023.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Ruan Y, Zhu X, Shen J, Chen H and Zhou G:
Mechanism of Nicotiflorin in San-Ye-Qing rhizome for
anti-inflammatory effect in ulcerative colitis. Phytomedicine.
129:1555642024. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Tang L, Liu Y, Tao H, Feng W, Ren C, Shu
Y, Luo R and Wang X: Combination of Youhua Kuijie Prescription and
sulfasalazine can alleviate experimental colitis via
IL-6/JAK2/STAT3 pathway. Front Pharmacol. 15:14375032024.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Shalaby M, Abdelaziz RR, Ghoneim HA and
Suddek GM: Imatinib mitigates experimentally-induced ulcerative
colitis: Possible contribution of NF-kB/JAK2/STAT3/COX2 signaling
pathway. Life Sci. 321:1215962023. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Yu T, Li Z, Xu L, Yang M and Zhou X:
Anti-inflammation effect of Qingchang suppository in ulcerative
colitis through JAK2/STAT3 signaling pathway in vitro and in vivo.
J Ethnopharmacol. 266:1134422021. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Jiang M, Zhong G, Zhu Y, Wang L, He Y, Sun
Q, Wu X, You X, Gao S, Tang D and Wang D: Retardant effect of
dihydroartemisinin on ulcerative colitis in a JAK2/STAT3-dependent
manner. Acta Biochim Biophys Sin (Shanghai). 53:1113–1123. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Wang X, Huang S, Zhang M, Su Y, Pan Z,
Liang J, Xie X, Wang Q, Chen J, Zhou L and Luo X: Gegen Qinlian
decoction activates AhR/IL-22 to repair intestinal barrier by
modulating gut microbiota-related tryptophan metabolism in
ulcerative colitis mice. J Ethnopharmacol. 302:1159192023.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Voshagh Q, Anoshiravani A, Karimpour A,
Goodarzi G, Tehrani SS, Tabatabaei-Malazy O and Panahi G:
Investigating the association between the tissue expression of
miRNA-101, JAK2/STAT3 with TNF-α, IL-6, IL-1β, and IL-10 cytokines
in the ulcerative colitis patients. Immun Inflamm Dis.
12:e12242024. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Miles EA and Calder PC: Effects of citrus
fruit juices and their bioactive components on inflammation and
immunity: A narrative review. Front Immunol. 12:7126082021.
View Article : Google Scholar : PubMed/NCBI
|
